209 related articles for article (PubMed ID: 19138995)
1. Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.
Lee HJ; Paul S; Atalla N; Thomas PE; Lin X; Yang I; Buckley B; Lu G; Zheng X; Lou YR; Conney AH; Maehr H; Adorini L; Uskokovic M; Suh N
Cancer Prev Res (Phila); 2008 Nov; 1(6):476-84. PubMed ID: 19138995
[TBL] [Abstract][Full Text] [Related]
2. Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling.
Lee HJ; So JY; DeCastro A; Smolarek A; Paul S; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):408-12. PubMed ID: 20304052
[TBL] [Abstract][Full Text] [Related]
3. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer.
So JY; Lee HJ; Smolarek AK; Paul S; Wang CX; Maehr H; Uskokovic M; Zheng X; Conney AH; Cai L; Liu F; Suh N
Mol Pharmacol; 2011 Mar; 79(3):360-7. PubMed ID: 21115634
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.
Wahler J; So JY; Kim YC; Liu F; Maehr H; Uskokovic M; Suh N
Cancer Prev Res (Phila); 2014 Jun; 7(6):617-26. PubMed ID: 24691501
[TBL] [Abstract][Full Text] [Related]
5. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.
So JY; Smolarek AK; Salerno DM; Maehr H; Uskokovic M; Liu F; Suh N
PLoS One; 2013; 8(1):e54020. PubMed ID: 23326564
[TBL] [Abstract][Full Text] [Related]
7. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
8. Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5).
Mehta R; Hawthorne M; Uselding L; Albinescu D; Moriarty R; Christov K; Mehta R
J Natl Cancer Inst; 2000 Nov; 92(22):1836-40. PubMed ID: 11078761
[TBL] [Abstract][Full Text] [Related]
9. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
Anzano MA; Smith JM; Uskoković MR; Peer CW; Mullen LT; Letterio JJ; Welsh MC; Shrader MW; Logsdon DL; Driver CL
Cancer Res; 1994 Apr; 54(7):1653-6. PubMed ID: 8137276
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.
Albert DM; Kumar A; Strugnell SA; Darjatmoko SR; Lokken JM; Lindstrom MJ; Patel S
Arch Ophthalmol; 2004 Sep; 122(9):1357-62. PubMed ID: 15364716
[TBL] [Abstract][Full Text] [Related]
11. MNU-induced mammary gland carcinogenesis: chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways.
Macejová D; Ondková S; Jakubíková L; Mlynarčíková A; Scsuková S; Liška J; Brtko J
Toxicol Lett; 2011 Nov; 207(1):60-72. PubMed ID: 21843606
[TBL] [Abstract][Full Text] [Related]
12. Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer.
Smolarek AK; So JY; Burgess B; Kong AN; Reuhl K; Lin Y; Shih WJ; Li G; Lee MJ; Chen YK; Yang CS; Suh N
Cancer Prev Res (Phila); 2012 Nov; 5(11):1310-20. PubMed ID: 22964476
[TBL] [Abstract][Full Text] [Related]
13. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
Abe J; Nakano T; Nishii Y; Matsumoto T; Ogata E; Ikeda K
Endocrinology; 1991 Aug; 129(2):832-7. PubMed ID: 1855478
[TBL] [Abstract][Full Text] [Related]
14. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.
Shabtay A; Sharabani H; Barvish Z; Kafka M; Amichay D; Levy J; Sharoni Y; Uskokovic MR; Studzinski GP; Danilenko M
Oncology; 2008; 75(3-4):203-14. PubMed ID: 18852491
[TBL] [Abstract][Full Text] [Related]
16. The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice.
Tran K; Risingsong R; Royce D; Williams CR; Sporn MB; Liby K
Cancer Prev Res (Phila); 2012 May; 5(5):726-34. PubMed ID: 22401982
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5.
Murillo G; Mehta RG
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):129-36. PubMed ID: 16051482
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway.
Thordarson G; Slusher N; Leong H; Ochoa D; Rajkumar L; Guzman R; Nandi S; Talamantes F
Breast Cancer Res; 2004; 6(4):R423-36. PubMed ID: 15217511
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
[TBL] [Abstract][Full Text] [Related]
20. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.
O'Kelly J; Uskokovic M; Lemp N; Vadgama J; Koeffler HP
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):107-16. PubMed ID: 16777406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
